| Authors: |
Dagnew AF; Gates Medical Research Institute, Cambridge, MA, USA. Electronic address: alemnew.dagnew@gatesmri.org., Noble R; Gates Medical Research Institute, Cambridge, MA, USA., Cinar A; Gates Medical Research Institute, Cambridge, MA, USA., Burhan E; Pulmonary Mycosis Centre, Jakarta, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia - Persahabatan Hospital, Jakarta, Indonesia; Respiratory Programmatic Implementation and Research Institute, Jakarta, Indonesia., Churchyard G; Aurum Institute, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa., Fairlie L; Wits RHI, University of Witwatersrand, Johannesburg, South Africa., Hanekom WA; Africa Health Research Institute, KwaZulu-Natal, South Africa., Muyoyeta M; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia., Mwandumba HC; Malawi Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Nduba V; Kenya Medical Research Institute, Centre for Respiratory Diseases Research (CRDR), Nairobi, Kenya., Curran M; Gates Medical Research Institute, Cambridge, MA, USA., Schmidt AC; Gates Medical Research Institute, Cambridge, MA, USA. |